Showing results (71-80 of 656) with videos related to
Sort By:
Pageof 66
The Lancet. Microbe|July 19, 2025
Global emergence and transmission dynamics of carbapenemase-producing Citrobacter freundii sequence type 22 high-risk international clone: a retrospective, genomic, epidemiological studyQiaojun Wang, Longjie Zhou, Xiaoling Chen, et al.The Lancet. Microbe|June 23, 2025
Diagnostic and phylogenetic perspectives of the 2023 Murray Valley encephalitis virus outbreak in Australia: an observational studyAnnaleise R Howard-Jones, Jackie E Mahar, Kate Proudmore, et al.The Lancet. Microbe|December 18, 2025
Attachment and replication of clade 2.3.4.4b influenza A (H5N1) viruses in human respiratory epithelium: an in-vitro studyLisa Bauer, Lonneke Leijten, Matteo Iervolino, et al.The Lancet. Microbe|November 30, 2025
HIV drug resistance during antiretroviral therapy scale-up in Uganda, 2012-19: a population-based, longitudinal studyMichael A Martin, Steven James Reynolds, Brian T Foley, et al.The Lancet. Microbe|December 19, 2024
Artemether-lumefantrine-amodiaquine or artesunate-amodiaquine combined with single low-dose primaquine to reduce Plasmodium falciparum malaria transmission in Ouélessébougou, Mali: a five-arm, phase 2, single-blind, randomised controlled trialAlmahamoudou Mahamar, Leen N Vanheer, Merel J Smit, et al.The Lancet. Microbe|December 21, 2024
Immune responses to SARS-CoV-2 in sub-Saharan Africa and western Europe: a retrospective, population-based, cross-sectional studyMoustapha Mbow, Dennis Hoving, Marouba Cisse, et al.The Lancet. Microbe|February 22, 2025
Controlled human infection model of Neisseria lactamica in late pregnancy investigating mother-to-infant transmission in the UK: a single-arm pilot trialAnastasia A Theodosiou, Debby Bogaert, David W Cleary, et al.The Lancet. Microbe|January 7, 2025
Protection by natural cholera against later episodes of cholera over 10 years of follow-up in Matlab, Bangladesh: a retrospective cohort studyMasuma Hoque, Deok Ryun Kim, Faisal Ahmmed, et al.The Lancet. Microbe|January 13, 2025
Evaluation of a novel malaria anti-sporozoite vaccine candidate, R21 in Matrix-M adjuvant, in the UK and Burkina Faso: two phase 1, first-in-human trialsNavin Venkatraman, Alfred B Tiono, Georgina Bowyer, et al.The Lancet. Microbe|December 9, 2024
Bacteriology testing and antimicrobial resistance detection capacity of national tiered laboratory networks in sub-Saharan Africa: an analysis from 14 countriesPascale Ondoa, Geetanjali Kapoor, Yewande Alimi, et al.Pageof 66